Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huangbai Capsule is a traditional Chinese medicine (TCM) herbal product developed and manufactured by Guangdong Xinfeng Pharmaceutical. The primary active ingredient is Phellodendron bark (*Phellodendron chinense* or *Phellodendron amurense*), known as Huangbai in TCM. It is formulated as an oral capsule containing yellow powder derived from the herbal material. According to TCM principles, it functions to clear heat, dry dampness, purge fire, and detoxify. It is clinically indicated for a variety of conditions associated with 'damp-heat' and 'fire-toxicity,' including dysentery, jaundice, vaginal discharge, urinary tract infections (hot strangury), and skin conditions such as eczema and carbuncles. Pharmacologically, Phellodendron extracts have demonstrated broad-spectrum antimicrobial activity against various pathogenic bacteria, including *Staphylococcus aureus*, *Salmonella typhi*, and *Mycobacterium tuberculosis*, as well as certain fungi.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Huangbai Capsule.